HDAC8 and cardiac hypertrophy: Accordingly, HDAC8 inhibition by PCI-34051 suppresses p38 activation, attenuates markers of cardiac hypertrophy and fibrosis, and suppresses cardiac hypertrophy in vitro and in the isoproterenol-induced cardiac hypertrophy mouse model [122].